0 results for 'Pfizer Inc'
Patent Suit Centers on Technology Used For COVID-19 Vaccine
This suit was surfaced by Law.com Radar. Read the document here.'Second-Best Year Ever': Paul Weiss Saw Slight Decline in Revenue as PEP Fell 7%
Firm chair Brad Karp said a decline in headcount was a consequence of "not over-hiring," and as associates left in the lateral market last year, the firm chose not to replace them.Deal Watch: Wachtell, SullCrom Lead $43B Biotech Deal, Failed Banks Muddy Deal Waters
Even the best week of M&A thus far in 2023 came with a wrinkle, as the collapse of two regional banks is spurring concerns about the overall banking apparatus in the United States.Federal Judge Dismisses Suit Alleging Legal Team Misled Plaintiff in Wage-and-Hour Suit vs. Wyeth
A Massachusetts federal judge has agreed to dismiss Pfizer and the plaintiff's former attorneys in the matter of a former Wyeth Pharmaceuticals employee who alleged his legal team misled him at various points during a wage-and-hour suit against his employer.Scientific Lab Behind Dozens of Product Recalls Under the Microscope
In lawsuits, GlaxoSmithKline, Unilever and others are challenging the scientific methods used by Valisure, the Connecticut laboratory whose reports have prompted recalls, and subsequent class actions, over drugs, sunscreen and dry shampoo.View more book results for the query "Pfizer Inc"
Boards' Lack of Tech Savvy Poses Challenges for CLOs
"The lawyers in our survey gave remarkably consistent comments. ... They see the key risk as the board. They worry over its composition, quality and experience," Baker McKenzie wrote in a recently released report.